Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$511M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$442M |
| 3 |
Microsoft
MSFT
|
+$392M |
| 4 |
Amazon
AMZN
|
+$348M |
| 5 |
Corteva
CTVA
|
+$288M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$419M |
| 2 |
Cisco
CSCO
|
+$141M |
| 3 |
Altria Group
MO
|
+$135M |
| 4 |
TJX Companies
TJX
|
+$114M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.3% |
| 2 | Financials | 15.46% |
| 3 | Healthcare | 13.81% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Heron Therapeutics
HRTX
$61.5M
| $16.7M | ﹤0.01% |
897,080
+81,852
| +10% | +$1.64M |
|
|
PRSU
1602
Pursuit Attractions and Hospitality Inc
PRSU
$1.26B
| $16.7M | ﹤0.01% |
251,613
+15,661
| +7% | +$966K |
|
1603
Brookdale Senior Living
BKD
$3B
| $16.6M | ﹤0.01% |
2,304,707
+104,757
| +5% | +$691K |
|
1604
SM Energy
SM
$7.73B
| $16.6M | ﹤0.01% |
1,327,182
+245,356
| +23% | +$3.56M |
|
|
VBTX
1605
DELISTED
Veritex Holdings
VBTX
| $16.6M | ﹤0.01% |
639,105
+92,384
| +17% | +$2.39M |
|
|
ALTR
1606
DELISTED
Altair Engineering Inc
ALTR
| $16.6M | ﹤0.01% |
409,956
+64,047
| +19% | +$2.39M |
|
|
PR
1607
Permian Resources
PR
$18B
| $16.5M | ﹤0.01% |
2,172,718
+110,212
| +5% | +$980K |
|
1608
AMERISAFE
AMSF
$519M
| $16.5M | ﹤0.01% |
258,334
+18,939
| +8% | +$1.13M |
|
|
BRKL
1609
DELISTED
Brookline Bancorp
BRKL
| $16.5M | ﹤0.01% |
1,071,024
+78,961
| +8% | +$1.18M |
|
1610
First Commonwealth Financial
FCF
$2.18B
| $16.4M | ﹤0.01% |
1,218,670
+13,683
| +1% | +$180K |
|
|
SNBR
1611
DELISTED
Sleep Number
SNBR
| $16.4M | ﹤0.01% |
406,113
-13,960
| -3% | -$539K |
|
|
SASR
1612
DELISTED
Sandy Spring Bancorp Inc
SASR
| $16.4M | ﹤0.01% |
469,671
+24,699
| +6% | +$831K |
|
|
RCM
1613
DELISTED
R1 RCM Inc. Common Stock
RCM
| $16.4M | ﹤0.01% |
1,302,273
+103,436
| +9% | +$1.17M |
|
1614
Veracyte
VCYT
$3.73B
| $16.4M | ﹤0.01% |
574,239
+127,555
| +29% | +$3.19M |
|
1615
BGC Group
BGC
$4.83B
| $16.3M | ﹤0.01% |
3,123,941
+88,970
| +3% | +$461K |
|
1616
Fate Therapeutics
FATE
$319M
| $16.3M | ﹤0.01% |
802,953
+12,082
| +2% | +$218K |
|
1617
Interparfums
IPAR
$3.84B
| $16.3M | ﹤0.01% |
245,151
+12,334
| +5% | +$861K |
|
1618
Usana Health Sciences
USNA
$254M
| $16.3M | ﹤0.01% |
204,875
-13,045
| -6% | -$1.03M |
|
|
FSCT
1619
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $16.3M | ﹤0.01% |
480,577
+156,775
| +48% | +$5.76M |
|
1620
Enpro
NPO
$7.12B
| $16.2M | ﹤0.01% |
254,510
+20,371
| +9% | +$1.33M |
|
|
ESPR
1621
DELISTED
Esperion Therapeutics
ESPR
| $16.2M | ﹤0.01% |
349,046
+54,332
| +18% | +$2.55M |
|
|
AVYA
1622
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $16.2M | ﹤0.01% |
1,360,883
+141,098
| +12% | +$2.16M |
|
|
GLUU
1623
DELISTED
Glu Mobile Inc.
GLUU
| $16.2M | ﹤0.01% |
2,257,508
+319,900
| +17% | +$2.94M |
|
|
BRSP
1624
BrightSpire Capital
BRSP
$626M
| $16.2M | ﹤0.01% |
1,042,366
+44,746
| +4% | +$700K |
|
1625
OFG Bancorp
OFG
$2.22B
| $16.1M | ﹤0.01% |
679,217
+13,711
| +2% | +$273K |
|
Similar funds
Geode Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Geode Capital Management held 4,308 positions worth $413B, up 7.1% from $386B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Geode Capital Management deployed $13.5B of net new capital in Q2 2019, opening 177 new positions and adding to 3,043 existing holdings. Its largest new stake was Dow Inc: 9,682,103 shares worth $477M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was DuPont de Nemours, an estimated $419M trimmed.
- Geode Capital Management's largest Q2 2019 buy was Dow Inc: 9,682,103 shares worth $477M.
- Geode Capital Management added most to Alphabet (Google) Class A in Q2 2019, an estimated $442M increase.
- Geode Capital Management's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $419M.
- Geode Capital Management fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $109M.
- Geode Capital Management's ten largest holdings make up 17% of its $413B portfolio in Q2 2019.
- Geode Capital Management opened 177 new positions and closed 101 in Q2 2019.
- Geode Capital Management's portfolio value rose 7.1% quarter-over-quarter to $413B.
Based on Geode Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.